Andrea Iaboni1,2,3, Susan E Bronskill4,5, Katelyn B Reynolds6, Xuesong Wang4, Paula A Rochon4,5,7,8, Nathan Herrmann6,9, Alastair J Flint10,6. 1. Centre for Mental Health, University Health Network, Toronto, ON, Canada. Andrea.iaboni@uhn.ca. 2. Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Andrea.iaboni@uhn.ca. 3. Toronto Rehabilitation Institute, 550 University Ave, 5-105-3, Toronto, ON, M5G 2A2, Canada. Andrea.iaboni@uhn.ca. 4. Institute for Clinical Evaluative Sciences, Toronto, ON, Canada. 5. Institute of Health, Policy Management and Evaluation, University of Toronto, Toronto, ON, Canada. 6. Department of Psychiatry, University of Toronto, Toronto, ON, Canada. 7. Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada. 8. Department of Medicine, University of Toronto, Toronto, ON, Canada. 9. Hurvitz Brain Sciences Program Sunnybrook Health Sciences Centre, Toronto, ON, Canada. 10. Centre for Mental Health, University Health Network, Toronto, ON, Canada.
Abstract
BACKGROUND: Benzodiazepine medications have well-documented side effects, and their prescription rates in older adults have been declining. Trazodone and quetiapine are medications with sedative properties when used at low doses and are commonly used off-label for sleep or behavioral symptoms in older adults. OBJECTIVE: Our objective was to describe the shifting patterns of sedative prescription in older adults over time by comparing changes in benzodiazepine, trazodone, and quetiapine dispensing between community and long-term care settings. METHODS: We conducted a population-based serial cross-sectional study to compare the patterns of sedative dispensing (specifically, benzodiazepines, trazodone, and quetiapine) to individuals aged ≥66 years between 1 January 2002 and 31 March 2013 in Ontario, Canada. We compared rates of use between long-term care and community settings and used linear regression models to characterize the magnitude and direction of the rate of change in sedative use by age, sex, and dementia status. RESULTS: The dispensing of trazodone and quetiapine increased over time, and this coincided with a decrease in benzodiazepine dispensing. This pattern was particularly apparent in the oldest cohort and in those with dementia. Benzodiazepines, trazodone, and quetiapine were associated with high rates of psychotropic polypharmacy. Overall trends were similar in long-term care and the community. CONCLUSIONS: While benzodiazepine prescribing is declining among older adults in Ontario over time, there is a corresponding shift towards low-dose, off-label prescribing of trazodone and quetiapine and psychotropic polypharmacy. These prescribing trends highlight sedative substitution and reinforce the need to confirm efficacy and safety of this practice.
BACKGROUND:Benzodiazepine medications have well-documented side effects, and their prescription rates in older adults have been declining. Trazodone and quetiapine are medications with sedative properties when used at low doses and are commonly used off-label for sleep or behavioral symptoms in older adults. OBJECTIVE: Our objective was to describe the shifting patterns of sedative prescription in older adults over time by comparing changes in benzodiazepine, trazodone, and quetiapine dispensing between community and long-term care settings. METHODS: We conducted a population-based serial cross-sectional study to compare the patterns of sedative dispensing (specifically, benzodiazepines, trazodone, and quetiapine) to individuals aged ≥66 years between 1 January 2002 and 31 March 2013 in Ontario, Canada. We compared rates of use between long-term care and community settings and used linear regression models to characterize the magnitude and direction of the rate of change in sedative use by age, sex, and dementia status. RESULTS: The dispensing of trazodone and quetiapine increased over time, and this coincided with a decrease in benzodiazepine dispensing. This pattern was particularly apparent in the oldest cohort and in those with dementia. Benzodiazepines, trazodone, and quetiapine were associated with high rates of psychotropic polypharmacy. Overall trends were similar in long-term care and the community. CONCLUSIONS: While benzodiazepine prescribing is declining among older adults in Ontario over time, there is a corresponding shift towards low-dose, off-label prescribing of trazodone and quetiapine and psychotropic polypharmacy. These prescribing trends highlight sedative substitution and reinforce the need to confirm efficacy and safety of this practice.
Authors: Cheryl L P Vigen; Wendy J Mack; Richard S E Keefe; Mary Sano; David L Sultzer; T Scott Stroup; Karen S Dagerman; John K Hsiao; Barry D Lebowitz; Constantine G Lyketsos; Pierre N Tariot; Ling Zheng; Lon S Schneider Journal: Am J Psychiatry Date: 2011-05-15 Impact factor: 18.112
Authors: Consuelo Huerta; Victoria Abbing-Karahagopian; Gema Requena; Belén Oliva; Yolanda Alvarez; Helga Gardarsdottir; Montserrat Miret; Cornelia Schneider; Miguel Gil; Patrick C Souverein; Marie L De Bruin; Jim Slattery; Mark C H De Groot; Ulrik Hesse; Marietta Rottenkolber; Sven Schmiedl; Dolores Montero; Andrew Bate; Ana Ruigomez; Luis Alberto García-Rodríguez; Saga Johansson; Frank de Vries; Raymond G Schlienger; Robert F Reynolds; Olaf H Klungel; Francisco José de Abajo Journal: Pharmacoepidemiol Drug Saf Date: 2015-07-07 Impact factor: 2.890
Authors: Muhammad Mamdani; Mark Rapoport; Kenneth I Shulman; Nathan Herrmann; Paula A Rochon Journal: Am J Geriatr Psychiatry Date: 2005-10 Impact factor: 4.105
Authors: Jonathan Brett; Donovan T Maust; Zach Bouck; Rosalinda V Ignacio; Graham Mecredy; Eve A Kerr; Sacha Bhatia; Adam G Elshaug; Sallie A Pearson Journal: J Am Geriatr Soc Date: 2018-02-12 Impact factor: 5.562
Authors: Andrea Iaboni; Michael A Campitelli; Susan E Bronskill; Christina Diong; Matthew Kumar; Laura C Maclagan; Tara Gomes; Mina Tadrous; Colleen J Maxwell Journal: CMAJ Open Date: 2019-09-23
Authors: Jennifer A Watt; Tara Gomes; Susan E Bronskill; Anjie Huang; Peter C Austin; Joanne M Ho; Sharon E Straus Journal: CMAJ Date: 2018-11-26 Impact factor: 8.262
Authors: Parker Magin; Amanda Tapley; Adrian J Dunlop; Andrew Davey; Mieke van Driel; Elizabeth Holliday; Simon Morgan; Kim Henderson; Jean Ball; Nigel Catzikiris; Katie Mulquiney; Neil Spike; Rohan Kerr; Simon Holliday Journal: J Gen Intern Med Date: 2018-07-23 Impact factor: 5.128
Authors: Heather L Neville; Mia Losier; Jennifer Pitman; Melissa Gehrig; Jennifer E Isenor; Laura V Minard; Ellen Penny; Susan K Bowles Journal: Can J Hosp Pharm Date: 2020-06-01
Authors: Donovan T Maust; Julie Strominger; H Myra Kim; Kenneth M Langa; Julie P W Bynum; Chiang-Hua Chang; Helen C Kales; Kara Zivin; Erica Solway; Steven C Marcus Journal: JAMA Date: 2021-03-09 Impact factor: 56.272